articleNature GeneticsMar 1, 2025HYBRID OA

Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma

Central South University · Xiangya Hospital Central South University · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Tumors undergo metabolic reprogramming to meet the energetic, synthetic and redox demands essential for malignancy, often characterized by increased glycolysis and lactate production. However, the role of mitochondrial metabolism in tumor immunity remains unclear. The present study integrates spatial transcriptomics, bulk transcriptomics and proteomics, revealing a strong link between the metabolite succinyl-CoA and tumor immunity as well as the efficacy of anti-programmed cell death protein-1 (PD-1) therapy in patients with melanoma. Elevated succinyl-CoA levels, through α-ketoglutarate or succinate supplementation, enhanced T cell-mediated tumor elimination, both in vitro and in vivo. Mechanistically,…

No related works found for this paper.

Funding